Live-attenuated virus vaccines are key components in controlling arboviral diseases, but they must not disseminate in or be transmitted by mosquito vectors. Although the cycles in which many mosquito-borne viruses are transmitted are well understood, the role of viral genetics in these processes has not been fully elucidated. Yellow fever virus (YFV) is an important arbovirus and the prototype member of the family Flaviviridae. Here, YFV was used in Aedes aegypti mosquitoes as a model to investigate the genetic basis of infection and dissemination in mosquitoes. Viruses derived from infectious clones and chimeric viruses with defined sequential manipulations were used to investigate the influence of specific sequences within the membrane and envelope structural protein genes on dissemination of virus from the mosquito midgut. Substitution of domain III of the envelope protein from a midgut-restricted YFV into a wild-type YFV resulted in a marked decrease in virus dissemination, suggesting an important role for domain III in this process. However, synergism between elements within the flavivirus structural and non-structural protein genes may be necessary for efficient virus escape from the mosquito midgut.
BlaneyJ. A.Jr,
JohnsonD. H.,
ManiponG. G.,
FirestoneC.-Y.,
HansonC. T.,
MurphyB. R.,
WhiteheadS. S.2002; Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells. Virology 300:125–139[CrossRef]
BlaneyJ. A.Jr,
HansonC. M.,
FirestoneC.-Y.,
HanleyK. A.,
MurphyB. R.,
WhiteheadS. S.2004; Genetically modified, live attenuated dengue virus type 3 vaccine candidates. Am J Trop Med Hyg 71:811–821
BraultA. C.,
PowersA. M.,
OrtizD.,
Estrada-FrancoJ. G.,
Navarro-LopesR.,
WeaverS. C.2004; Venezuelan equine encephalitis emergence: enhanced vector infection from a single amino acid substitution in the envelope glycoprotein. Proc Natl Acad Sci U S A 101:11344–11349[CrossRef]
BredenbeekP. J.,
KooiE. A.,
LindenbachB.,
HuijkmanN.,
RiceC. M.,
SpaanW. J. M.2003; A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication. J Gen Virol 84:1261–1268[CrossRef]
CatteauA.,
KalininaO.,
WagnerM.-C.,
DeubelV.,
CourageotM.-P.,
DesprèsP.2003; Dengue virus M protein contains a proapoptotic sequence referred to as ApoptoM
. J Gen Virol 84:2781–2793[CrossRef]
DunsterL. M.,
WangH.,
RymanK. D.,
MillerB. R.,
WatowichS. J.,
MinorP. D.,
BarrettA. D. T.1999; Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus. Virology 261:309–318[CrossRef]
HiggsS.2004; How do mosquito vectors live with their viruses?. In Microbe–Vector Interactions in Vector-Borne Diseases pp 103–137 Edited by
GillespieS. H.,
SmithG. L.,
OsbournA.
Cambridge: Cambridge University Press;
HiggsS.,
OlsonK. E.,
KamrudK. I.,
PowersA. M.,
BeatyB. J.1997; Viral expression systems and viral infections in insects. In The Molecular Biology of Insect Disease Vectors: a Methods Manual pp 459–483 Edited by
CramptonJ. M.,
BeardC. B.,
LouisC.
London: Chapman;
HoltR. A.,
SubramanianG. M.,
HalpernA.& 121 other authors2002; The genome sequence of the malaria mosquito Anopheles gambiae
. Science 298:129–149[CrossRef]
HombachJ.,
BarrettA. D.,
CardosaM. J.,
DeubelV.,
GuzmanM.,
KuraneI.,
RoehrigJ. T.,
SabchareonA.,
KienyM. P.2005; Review on flavivirus vaccine development. Proceedings of a meeting jointly organized by the World Health Organization and the Thai Ministry of Public Health26–27 April 2004 Bangkok, Thailand: Vaccine 23:2689–2695[CrossRef]
JenningsA. D.,
GibsonC. A.,
MillerB. R.& 11 other authors1994; Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis. J Infect Dis 169:512–518[CrossRef]
JohnsonB. W.,
ChambersT. V.,
CrabtreeM. B.,
BhattT. R.,
GuirakhooF.,
MonathT. P.,
MillerB. R.2002; Growth characteristics of ChimeriVaxTM-DEN2 vaccine virus in Aedes aegypti and Aedes albopictus mosquitoes. Am J Trop Med Hyg 67:260–265
JohnsonB. W.,
ChambersT. V.,
CrabtreeM. B.,
ArroyoJ.,
MonathT. P.,
MillerB. R.2003; Growth characteristics of the veterinary vaccine candidate ChimeriVaxTM-West Nile (WN) virus in Aedes and Culex mosquitoes. Med Vet Entomol 17:235–243[CrossRef]
LudwigG. V.,
IsrealB. A.,
ChristensenB. M.,
YuillT. M.,
SchultzK. T.1991; Role of La Crosse virus glycoproteins in attachment of virus to host cells. Virology 181:564–571[CrossRef]
McElroyK. L.,
TsetsarkinK. A.,
VanlandinghamD. L.,
HiggsS.2005; Characterization of an infectious clone of the wild-type yellow fever virus Asibi strain that is able to infect and disseminate in mosquitoes. J Gen Virol 86:1747–1751[CrossRef]
MillerB. R.1987; Increased yellow fever virus infection and dissemination rates in Aedes aegypti mosquitoes orally exposed to freshly grown virus. Trans R Soc Trop Med Hyg 81:1011–1012[CrossRef]
MillerB. R.,
MitchellC. J.1991; Genetic selection of a flavivirus-refractory strain of the yellow fever mosquito Aedes aegypti
. Am J Trop Med Hyg 45:399–407
MylesK. M.,
PierroD. J.,
OlsonK. E.2003; Deletions in the putative cell receptor-binding domain of Sindbis virus strain MRE16 E2 glycoprotein reduce midgut infectivity in Aedes aegypti
. J Virol 77:8872–8881[CrossRef]
Op De BeeckA.,
RouilléY.,
CaronM.,
DuvetS.,
DubuissonJ.2004; The transmembrane domains of the prM and E proteins of yellow fever virus are endoplasmic reticulum localization signals. J Virol 78:12591–12602[CrossRef]
ReyF. A.,
HeinzF. X.,
MandlC.,
KunzC.,
HarrisonS. C.1995; The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375:291–298[CrossRef]
SundinD. R.,
BeatyB. J.,
NathansonM.,
Gonzales-ScaranoF.1987; A G1 glycoprotein epitope of La Crosse virus: a determinant of infection of Aedes triseriatus
. Science 235:591–593[CrossRef]
TabachnickW. J.2003; Reflections on the Anopheles gambiae genome sequence, transgenic mosquitoes and the prospect for controlling malaria and other vector borne diseases. J Med Entomol 40:597–606[CrossRef]
TabachnickW. J.,
WallisG. P.,
AitkenT. H.,
MillerB. R.,
AmatoG. D.,
LorenzL.,
PowellJ. R.,
BeatyB. J.1985; Oral infection of Aedes aegypti with yellow fever virus: geographic variation and genetic considerations. Am J Trop Med Hyg 34:1219–1224
VanlandinghamD. L.,
HongC.,
KlinglerK.,
TsetsarkinK.,
McElroyK. L.,
PowersA. M.,
LehaneM. J.,
HiggsS.2005; Differential infectivities of o'nyong-nyong and chikungunya virus isolates in Anopheles gambiae and Aedes aegypti mosquitoes. Am J Trop Med Hyg 72:616–621
WangH.,
RymanK. D.,
JenningsA. D.,
WoodA. J.,
TaffsF.,
MinorP. D.,
SandersP. G.,
BarrettA. D.1995; Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine. J Gen Virol 76:2749–2755[CrossRef]
WhiteheadS. S.,
HanleyK. A.,
BlaneyJ. A.Jr,
GilmoreL. E.,
ElkinsW. R.,
MurphyB. R.2003; Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated in mosquitoes, mice, and rhesus monkeys. Vaccine 21:4307–4316[CrossRef]
WoodwardT. M.,
MillerB. R.,
BeatyB. J.,
TrentD. W.,
RoehrigJ. T.1991; A single amino acid change in the E2 glycoprotein of Venezuelan equine encephalitis virus affects replication and dissemination in Aedes aegypti mosquitoes. J Gen Virol 72:2431–2435[CrossRef]
YunS.-I.,
KimS.-Y.,
RiceC. M.,
LeeY.-M.2003; Development and application of a reverse genetics system for Japanese encephalitis virus. J Virol 77:6450–6465[CrossRef]